Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...

David Eichenbaum, MD and Riad Sherif, MD, CEO of Oculis will present the updates with additional info on topline results from ...

AD is a neurodegenerative disease characterized by neuronal loss in the cerebral cortex and the formation of extracellular ...

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.